Inventor

BACH NICHOLAS J

US48 patents

Patents

48 patents

US5919774AJul 6, 1999

6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds

LILLY CO ELI52 citations96

US4110339AAug 29, 1978

4-(Di-n-propyl)amino-1,3,4,5-tetrahydrobenz[cd]indole

LILLY CO ELI51 citations96

US4198415AApr 15, 1980

Prolactin inhibiting octahydro pyrazolo[3,4-g]quinolines

LILLY CO ELI39 citations92

US5684034ANov 4, 1997

1H-indole-3-acetamide sPLA2 inhibitors

LILLY CO ELI41 citations90

US5578634ANov 26, 1996

1H-indole-3-acetic acid hydrazide sPLA2 inhibitors

LILLY CO ELI41 citations90

US4246265AJan 20, 1981

6-n-Propyl-8α-methoxymethyl or methylmercaptomethylergolines and related compounds

LILLY CO ELI20 citations82

US4235909ANov 25, 1980

Octahydro-2H-pyrrolo[3,4-g]quinolines

LILLY CO ELI21 citations82

US4202979AMay 13, 1980

6-Ethyl(or allyl)-8-methoxymethyl or methylmercaptomethylergolines and related compounds

LILLY CO ELI23 citations82

US4054660AOct 18, 1977

Method of inhibiting prolactin

LILLY CO ELI31 citations82

US4031097AJun 21, 1977

Descarboxylysergic acid

LILLY CO ELI19 citations82

US4448990AMay 15, 1984

Hydroxyaminotetralincarboxamides

LILLY CO ELI7 citations74

US4235776ANov 25, 1980

Tetrahydro-2H-benzo[c]pyrroles

LILLY CO ELI11 citations74

US4230861AOct 28, 1980

1-And/or 7-substituted-6-hydroxy (or oxo)-3-decahydroquinoline carboxylic acids

LILLY CO ELI16 citations74

US4180582ADec 25, 1979

6-n-Propyl-8-methoxy-methyl or methylmercaptomethylergolines and related compounds as prolactin inhibitors and to treat Parkinson's syndrome

LILLY CO ELI11 citations74

US3968111AJul 6, 1976

8,8-Disubstituted-6-methylergolines and related compounds

LILLY CO ELI9 citations74

US3959288AMay 25, 1976

8-Oxymethylergolines and process therefor

LILLY CO ELI17 citations74

US5919810AJul 6, 1999

1H-indole-3-glyoxylamide sPLA2 inhibitors

LILLY CO ELI4 citations73

US5919943AJul 6, 1999

Process for preparing 1H-indole-3-glyoxylamides

LILLY CO ELI5 citations73

US5733923AMar 31, 1998

1H-indole-3-glyoxylamide sPLA2 inhibitors

LILLY CO ELI7 citations73

US6350774B1Feb 26, 2002

Antithrombotic agents

LILLY CO ELI7 citations72

US6252084B1Jun 26, 2001

1H-indole-3-acetamide sPLA2 inhibitors

LILLY CO ELI12 citations71

US4500545AFeb 19, 1985

Hydroxyaminotetralincarboxamides

LILLY CO ELI3 citations63

US4367231AJan 4, 1983

Method of using octahydro pyrazolo[3,4-g]quinolines

LILLY CO ELI4 citations63

US4264622AApr 28, 1981

Tetrahydro-2H-benzo[c]pyrroles to inhibit prolactin secretion

LILLY CO ELI2 citations63

US4201862AMay 6, 1980

2-Azaergolines and 2-aza-8(or 9)-ergolenes

LILLY CO ELI5 citations63

US4098790AJul 4, 1978

Ergoline chlorination process

LILLY CO ELI2 citations63

US4075212AFeb 21, 1978

Method of preparing 8,8-disubstituted-6-methylergolines and related compounds

LILLY CO ELI3 citations63

US4001242AJan 4, 1977

D-6-methyl-8-formyl-10α-alkoxy-8-ergolene

LILLY CO ELI2 citations63

US3992385ANov 16, 1976

2,3-Dihydroergolines

LILLY CO ELI5 citations63

US3985752AOct 12, 1976

6-Methyl-8-(substituted) methylergolines

LILLY CO ELI4 citations63

US3968112AJul 6, 1976

Synthesis of penniclavine and elymoclavine

LILLY CO ELI5 citations63

US3954772AMay 4, 1976

Descarboxylysergic acid

LILLY CO ELI3 citations63

US6433001B1Aug 13, 2002

1H-indole-3-glyoxylamide sPLA2 inhibitors

LILLY CO ELI3 citations62

US6175021B1Jan 16, 2001

1H-indole-3-glyoxylamide sPLA2 inhibitors

LILLY CO ELI3 citations62

US4683313AJul 28, 1987

2-alkyl(or phenyl)thio-6-N alkyl ergolines and 4-dialkylaminotetrahydrobenz[c,d]indoles

LILLY CO ELI3 citations61

US4322540AMar 30, 1982

Substituted 4,5,6,7-tetrahydro-1H (or 2H)-indazoles

LILLY CO ELI0 citations52

US4311844AJan 19, 1982

Octahydro-2H-pyrrolo[3,4,-g]quinolines

LILLY CO ELI1 citations52

US4282362AAug 4, 1981

Octahydro-2H-pyrrolo[3,4-g]quinolines

LILLY CO ELI0 citations52

US4276300AJun 30, 1981

Amino-substituted-4,5,6,7-tetrahydro-1H (or 2H)-indazoles

LILLY CO ELI1 citations52

US4082753AApr 4, 1978

Penniclavine acetonide

LILLY CO ELI1 citations52

US4075213AFeb 21, 1978

8-Aryl-9-ergolenes

LILLY CO ELI1 citations52

US4054567AOct 18, 1977

6-Methyl-8β-hydroxymethyl-8-γ-substituted-9-ergolene compounds

LILLY CO ELI0 citations52

US3962253AJun 8, 1976

Oxidation of selectively protected 2,3-dihydro-6-methyl-8-hydroxy-9-ergolenes

LILLY CO ELI0 citations52

US4801712AJan 31, 1989

2-Alkyl(or phenyl)thio-6-n-alkylergolines are dopamine D-1 antagonists without D-2 agonist activity

LILLY CO ELI0 citations50

US4322430AMar 30, 1982

Amino-substituted 4,5,6,7-tetrahydro-1H (or 2H)-indazoles

LILLY CO ELI0 citations42

BACH NICHOLAS J

Patents

Pyrroles as sPLA2 inhibitors

1H-indole-3-glyoxylamide SPLA2 inhibitors

1H-indole-1-functional sPLA2 inhibitors

6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds

4-(Di-n-propyl)amino-1,3,4,5-tetrahydrobenz[cd]indole

Prolactin inhibiting octahydro pyrazolo[3,4-g]quinolines

1H-indole-3-acetamide sPLA2 inhibitors

1H-indole-3-acetic acid hydrazide sPLA2 inhibitors

6-n-Propyl-8α-methoxymethyl or methylmercaptomethylergolines and related compounds

Octahydro-2H-pyrrolo[3,4-g]quinolines

6-Ethyl(or allyl)-8-methoxymethyl or methylmercaptomethylergolines and related compounds

Method of inhibiting prolactin

Descarboxylysergic acid

Hydroxyaminotetralincarboxamides

Tetrahydro-2H-benzo[c]pyrroles

1-And/or 7-substituted-6-hydroxy (or oxo)-3-decahydroquinoline carboxylic acids

6-n-Propyl-8-methoxy-methyl or methylmercaptomethylergolines and related compounds as prolactin inhibitors and to treat Parkinson&#39;s syndrome

8,8-Disubstituted-6-methylergolines and related compounds

8-Oxymethylergolines and process therefor

1H-indole-3-glyoxylamide sPLA2 inhibitors

Process for preparing 1H-indole-3-glyoxylamides

1H-indole-3-glyoxylamide sPLA2 inhibitors

Antithrombotic agents

1H-indole-3-acetamide sPLA2 inhibitors

Hydroxyaminotetralincarboxamides

Method of using octahydro pyrazolo[3,4-g]quinolines

Tetrahydro-2H-benzo[c]pyrroles to inhibit prolactin secretion

2-Azaergolines and 2-aza-8(or 9)-ergolenes

Ergoline chlorination process

Method of preparing 8,8-disubstituted-6-methylergolines and related compounds

D-6-methyl-8-formyl-10α-alkoxy-8-ergolene

2,3-Dihydroergolines

6-Methyl-8-(substituted) methylergolines

Synthesis of penniclavine and elymoclavine

Descarboxylysergic acid

1H-indole-3-glyoxylamide sPLA2 inhibitors

1H-indole-3-glyoxylamide sPLA2 inhibitors

2-alkyl(or phenyl)thio-6-N alkyl ergolines and 4-dialkylaminotetrahydrobenz[c,d]indoles

Substituted 4,5,6,7-tetrahydro-1H (or 2H)-indazoles

Octahydro-2H-pyrrolo[3,4,-g]quinolines

Octahydro-2H-pyrrolo[3,4-g]quinolines

Amino-substituted-4,5,6,7-tetrahydro-1H (or 2H)-indazoles

Penniclavine acetonide

8-Aryl-9-ergolenes

6-Methyl-8β-hydroxymethyl-8-γ-substituted-9-ergolene compounds

Oxidation of selectively protected 2,3-dihydro-6-methyl-8-hydroxy-9-ergolenes

2-Alkyl(or phenyl)thio-6-n-alkylergolines are dopamine D-1 antagonists without D-2 agonist activity

Amino-substituted 4,5,6,7-tetrahydro-1H (or 2H)-indazoles

6-n-Propyl-8-methoxy-methyl or methylmercaptomethylergolines and related compounds as prolactin inhibitors and to treat Parkinson's syndrome